NDC11 00121077001
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 00121-0770-01 | 00121-0770 |
| 00121-0770-1 | 00121-0770 |
| 00121-770-01 | 00121-770 |
| 0121-0770-01 | 0121-0770 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lorazepam | LORAZEPAM | Pharmaceutical Associates, Inc. | 711b60a3-028d-41d4-aa17-8f976e6df23e | 2022-08-11 | Boxed warning, Warnings, Adverse reactions | 0121-0770-01 0121-0770 00121077001 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.